The effect of diet in infancy on asthma in young adults: the Merthyr Allergy Prevention Study

Sadiyah Hand1, Frank Dunstan2, Ken Jones3

  • 1Department of Respiratory Medicine, Norfolk and Norwich University Hospital, Norwich, Norfolk, UK.

Thorax
|May 8, 2021
PubMed

Insights

Early infant diet impacts allergy risk. Cow's milk exclusion or soy milk introduction in the first four months increased adult risks of atopy and asthma in high-risk infants.

Area of Science:

  • Allergy and immunology
  • Pediatric allergy
  • Nutritional immunology

Background:

  • Early infant diet is a potential factor influencing the development of allergic diseases.
  • The Merthyr Allergy Prevention Study (MAPS) investigated the long-term effects of early infant feeding on allergic disease risk.

Purpose of the Study:

  • To determine if a cow's milk exclusion diet in the first four months of life reduces the risk of allergic diseases, including asthma, compared to a normal diet.
  • To assess the impact of early soya milk introduction on allergic disease risk.

Main Methods:

  • A randomized controlled trial (MAPS) involving high-risk infants.
  • Intervention group received a soya milk preparation; control group received a normal diet.
  • Standardized questionnaires and clinical assessments were conducted at multiple time points up to age 23 years.

Main Results:

  • Infants in the intervention group showed a significantly increased risk of atopy (adjusted OR 2.97) and asthma (OR 2.07) at age 23.
  • No significant increase in wheeze risk was observed in the intervention group (OR 1.43).
  • Early cow's milk exposure correlated with decreased wheeze and asthma risk; early soya milk exposure correlated with increased atopy and asthma risk.

Conclusions:

  • Cow's milk exclusion or early soya milk introduction in the first four months of life is associated with an increased risk of atopy, wheeze, and asthma in adulthood for high-risk infants.
  • These findings suggest that early dietary interventions in infancy may have long-term implications for allergic disease development.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.9K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
909
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.4K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.5K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.8K